Cite
MLA Citation
David Liang and Maurizio Sessa. “Post-marketing safety surveillance of erenumab: new insight from Eudravigilance.” Expert opinion on drug safety, vol. 21, no. 9, 2022, pp. 1205–1210. http://access.bl.uk/ark:/81055/vdc_100168332703.0x00001d